icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 23-26 2021
Back grey_arrow_rt.gif
 
 
 
Concordance Between SVR4, SVR12, and SVR24 in HCV-Infected Patients Who Received Fixed-Dose Combination Sofosbuvir/Velpatasvir in Phase 3 Clinical Trials
 
 
  EASL International Liver Congress, June 23-26, 2021
 
M. SULKOWSKI1, J. FELD2, N. REAU3, S. SCHERBAKOVSKY4, C. HERNANDEZ4, K. VANSTRAELEN4, K. HAMMOND4, B. KRETER4, V. SURI4, L. NI4, M. BOURLIERE5, A. MANGIA6
1Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Canada; 3Rush University Medical Center, Chicago, IL, USA; 4Gilead Sciences, Inc., Foster City, CA; 5H˘pital Saint Joseph, Marseilles, France; 6Fondazione "Casa Sollievo Della Sofferenza" IRCCS, San Giovanni Rotondo, Italy

0624211

0624212

0624213

0624214

0624215

0624216

0624217